Business
Why did the Exopharm (ASX:EX1) share price surge 12% today?
The Exopharm Ltd (ASX: EX1) share price rocketed today after the company announced positive clinical trial results for its regenerative medical product, Plexaris.
At market close, the Exopharm share price is up by 12.93% today to 65 cents per share.
Exopharm is a biopharmaceutical company focused on developing regenerative medicine. It’s currently investigating the therapeutic potential of two products, Plexaris and Cevaris, in treating osteoarthritis.
The company was undergoing clinical trials to see if the medicine can restore arthritic cell tissue in rats. These clinical trials showed that the drugs had no adverse affects and were safe to trial on humans, however they also showed that drugs’ efficacy was limited to milder…
-
General20 hours agoWallabies vs Italy rugby union Test live updates — blog, scores and stats from Udine
-
General19 hours agoHow the dismissal of Gough Whitlam’s Labor government in 1975 was sealed by the Senate
-
Noosa News11 hours agoPhotographer Nadia Shevtsova remembered by family in touching tribute after deadly crash at Gold Coast
-
General23 hours agoIsrael identifies latest hostage body as Lior Rudaeff, as families await five more